Are Strong Financial Prospects The Force That Is Driving The Momentum In Third Age Health Services Limited’s NZSE:TAH) Stock?

Third Age Health Services’ (NZSE:TAH) stock is up by a considerable 12% over the past three months. Given the company’s impressive performance, we decided to study its financial indicators more closely as a company’s financial health over the long-term usually dictates market outcomes. In this article, we decided to focus on Third Age Health Services’ ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company’s management is utilizing the company’s capital. In simpler terms, it measures the profitability of a company in relation to shareholder’s equity.

Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

The formula for return on equity is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Third Age Health Services is:

62% = NZ$2.5m ÷ NZ$4.0m (Based on the trailing twelve months to March 2025).

The ‘return’ refers to a company’s earnings over the last year. That means that for every NZ$1 worth of shareholders’ equity, the company generated NZ$0.62 in profit.

Check out our latest analysis for Third Age Health Services

We have already established that ROE serves as an efficient profit-generating gauge for a company’s future earnings. Depending on how much of these profits the company reinvests or “retains”, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.

To begin with, Third Age Health Services has a pretty high ROE which is interesting. Secondly, even when compared to the industry average of 11% the company’s ROE is quite impressive. Probably as a result of this, Third Age Health Services was able to see a decent net income growth of 14% over the last five years.

As a next step, we compared Third Age Health Services’ net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 6.6%.

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Third Age Health Services is trading on a high P/E or a low P/E, relative to its industry.

While Third Age Health Services has a three-year median payout ratio of 75% (which means it retains 25% of profits), the company has still seen a fair bit of earnings growth in the past, meaning that its high payout ratio hasn’t hampered its ability to grow.

Moreover, Third Age Health Services is determined to keep sharing its profits with shareholders which we infer from its long history of four years of paying a dividend.

Overall, we are quite pleased with Third Age Health Services’ performance. We are particularly impressed by the considerable earnings growth posted by the company, which was likely backed by its high ROE. While the company is paying out most of its earnings as dividends, it has been able to grow its earnings in spite of it, so that’s probably a good sign. Up till now, we’ve only made a short study of the company’s growth data. You can do your own research on Third Age Health Services and see how it has performed in the past by looking at this FREE detailed graph of past earnings, revenue and cash flows.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.